What Is Going On With Plandai Biotechnology Inc (OTCMKTS:PLPL) And Amgen, Inc. (NASDAQ:AMGN)?

Plandai Biotechnology Inc (OTCMKTS:PLPL) is one of the OTC traded stocks that have been under investors radar in this year. Recently, the company confirmed an amendment to its previously finalized contract with USN Worldwide. As per the new deal, Plandai will expand its Phytofare® complex sales to USN and related contract manufacturer entities to the […]

Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs

Plandai Biotechnology Inc (OTCMKTS:PLPL) and Generex Biotechnology Corporation (OTCMKTS:GNBT) are the two OTC traded stocks that have been the center of attraction after they issued promising PRs. Plandai reported an amendment to its preciously finalized deal with USN Worldwide. Under the new amended deal with USN, it will now expand its Phytofare® sales to USN […]

Ventrus Biosciences Inc (NASDAQ:VTUS) And Lorillard Inc. (NYSE:LO) But Generex Biotechnology Corporation (OTCMKTS:GNBT) Shows Promise

Boston, MA 02/13/2014 (wallstreetpr) – Ventrus Biosciences Inc (NASDAQ:VTUS)’s treatment for anal fissures did not give better results than a placebo. The news saw the stock of the company losing more than 63% of its value in a day. The first phase 3 trial had shown better results but in the pivotal second phase 3 […]

Generex Biotechnology Corporation (OTCMKTS:GNBT) Proprietary Technology

Boston, MA 02/12/2014 (wallstreetpr) – Generex Biotechnology Corporation (OTCMKTS:GNBT) is a Toronto-based drug delivery system developer with special focus on systems and technology for delivery of diabetes management drugs. The company strives to offer delivery systems on the commercial level, considering the high incidence of diabetes in the recent decades. Generex Biotechnology Corporation (OTCMKTS:GNBT) successful […]